News | Patient Positioning Radiation Therapy | October 25, 2018

Brainlab Introduces ExacTrac Dynamic at ASTRO 2018

Radiotherapy patient positioning and monitoring technology now consolidates multiple spatial tracking technologies

Brainlab Introduces ExacTrac Dynamic at ASTRO 2018
Radiotherapy patient positioning and monitoring technology now consolidates multiple spatial tracking technologies

October 25, 2018 — Brainlab unveiled ExacTrac Dynamic at the American Society for Radiation Oncology (ASTRO) meeting, Oct. 21-24 in San Antonio, Texas. This concept for radiotherapy patient positioning and monitoring offers value on multiple fronts, including expanded clinical indications, broad technological advancements, enhanced user and patient experience, and technology consolidation. ExacTrac Dynamic is the next generation of ExacTrac X-Ray, Brainlab’s positioning and monitoring solution for radiotherapy treatments.

ExacTrac Dynamic addresses a full range of patient positioning and monitoring requirements that heretofore have been achieved, in most cases, by employing multiple systems combined with different internal tracking and surface scanning technologies. ExacTrac Dynamic is seamlessly integrated with a wide range of high-end linear accelerators and designed to deliver high-precision tracking and verification, while addressing the challenges associated with treating moving targets. All of these are critical requirements for delivering extremely effective and high doses in precision radiotherapy.

“We had the opportunity to be the first institution to enter into a strategic partnership for the development of ExacTrac Dynamic, as we were looking for a technology that could become the new standard for patient positioning and monitoring in Copenhagen,” commented Lars Dahl Allerup, new business development manager, corporate procurement, Capital Region of Denmark. “As a long standing partner of Brainlab, we have always been convinced of the superior performance of ExacTrac X-Ray for cranial treatments. What is important for us moving forward is to source technology like ExacTrac Dynamic that allows us to continue treating cranial indications but also take care of the larger patient population at the Herlev Hospital and Rigshospitalet, with a platform redesigned to monitor all external beam treatment indications.”

New high-speed surface tracking incorporates 300,000 3-D surface points to externally monitor patient position and detect movement during treatment. Each of the surface points acquired by the ExacTrac Dynamic structured light system are matched to a heat signal generated by a thermal camera, creating another dimension in which to track the patient’s position consistently and with great accuracy. The advanced surface tracking with ExacTrac Dynamic is not impacted by room lighting, reflections or skin tone, and has very low latency.

Internal motion caused by normal respiration must be addressed to ensure safe and effective treatments. In addition to external tracking, integrated X-ray monitoring with ExacTrac Dynamic verifies the patient’s position internally with real-time imaging, at any treatment position. The system offers ways to monitor clinical indications that are complicated by internal motion with additional workflows, such as deep inspiration breath hold and internal anatomy verification, providing confidence in true dose sparing of critical anatomy.

Customers will still take advantage of ExacTrac X-ray’s historical benefits, including high performance, non-coplanar capabilities and submillimetric precision. Cranial positioning and monitoring offers streamlined immobilization, non-coplanar imaging, Mu-triggered monitoring and gantry-angle triggered monitoring.

ExacTrac Dynamic simplifies frameless fixation with three moldable thermoplastic mask options designed with patient comfort in mind. Deep integration with linear accelerators from both Elekta and Varian Medical Systems allow positioning and monitoring workflows to function seamlessly, including automatic patient loading, gantry triggered imaging and automated beam-hold.

For more information: www.brainlab.com

Related Content

Scientists have identified two subtypes of metastatic prostate cancer that respond differently to treatment, information that could one day guide physicians in treating patients with the therapies best suited to their disease.

Getty Images

News | Prostate Cancer | September 24, 2021
September 24, 2021 — Scientists have identified two subtypes of metastatic...
The "Global Surface Guided Radiation Therapy (SGRT) Devices Market, By Device Type (Portable v/s Fixed), By Application (Breast Cancer, Head & Neck Cancer, Abdominal & Pelvic Cancer, Dermatology, Others), By End User, By Region, Competition Forecast & Opportunities, 2026" report

Image courtesy of Varian

News | Radiation Therapy | September 24, 2021
September 24, 2021 — The ...
The National Cancer Institute announced that Virginia Commonwealth University Massey Cancer Center, Medical University of South Carolina Hollings Cancer Center and City of Hope Comprehensive Cancer Center secured a highly competitive Specialized Program of Research Excellence (SPORE) grant that aims to address lung cancer racial disparities through precision medicine, targeted smoking cessation programs and community outreach.

VCU Massey Cancer Center director and SPORE principal investigator Dr. Robert Winn explains how this grant will help combat racial inequities in lung cancer. Image courtesy of VCU Massey Cancer Center

News | Lung Imaging | September 23, 2021
September 23, 2021 — The National Cancer Institute announced tha
The development of new research guidelines for interventional oncology that standardize treatment outcomes and the reporting of data represents a major step forward for an increasingly important medical subspecialty, according to a report in Radiology.

Getty Images

News | Radiation Oncology | September 21, 2021
September 21, 2021 — The development of new research guidelines for interventional oncology that standardize treatmen
Non-oncology doctors’ knowledge of oncology is frequently not up to date, with risks in the communication with patients  

Getty Images

News | Radiation Oncology | September 20, 2021
September 20, 2021 — The rapid pace of developments in the oncology field, mainly brought by cancer immunotherapy, me
IBA (Ion Beam Applications S.A., EURONEXT), a world leader in particle accelerator technology, and SCK CEN (Belgian Nuclear Research Center) announced a strategic R&D partnership to enable the production of Actinimum-225 (225Ac), a novel radioisotope which has significant potential in the treatment of cancer.
News | Radiation Oncology | September 17, 2021
September 17, 2021 — IBA (Ion Beam Applications S.A., EURONEXT), a world leader in particle accelerator technology, a
Evaluation of therapeutic efficacy of drug candidates in preclinical oncology with positron emission tomography (PET)

Getty Images

Feature | PET Imaging | September 14, 2021 | By Todd Sasser, Ph.D.
With a wealth of landmark studies in Breast, Cervical, Melanoma, Prostate, Colorectal, Oesophagus, Endocrine and Lung cancer, the ESMO Congress 2021 is a clear demonstration that oncology research has once again gathered momentum after being temporarily stopped in its tracks by the outbreak of the virus

Getty Images

News | Radiation Oncology | September 13, 2021
September 13, 2021 — At the opening press conference of the ...
Comment letters on the 2022 physician fee schedule and Radiation Oncology Model urge CMS to scale back extreme cuts that jeopardize access to life-saving cancer treatments

Getty Images

News | ASTRO | September 09, 2021
September 9, 2021 — The American Society for Radiation Oncology (AS...